Add to Watchlist
View Current for JAGX
View SuperFeed for JAGX
View Charts for JAGX
Add or remove $JAGX from your watchlists:
Hang tight! We're updating your watchlist data. This might take a minute...
You have not created a stock watchlist.
Create one now to track $JAGX!
Done
Manage Watchlists
Jaguar Animal Health Inc
Health Care
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointes…
more
Conversation Volume
Last 60 days
There is not enough conversation volume about this stock
Key Opinion Leaders
Strongest 30-day focus on $JAGX by total mentions
Real-time Chart
Price Chart for $JAGX
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $JAGX
There are no threads for this stock
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Today
Past 7 days
Past 30 days
Past 60 days
Custom
Company Profile
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.
Market Cap Type: Small
Close
Date,Time,Temperature
2024-03-29,9,0
2024-03-29,10,0
2024-03-29,11,0
2024-03-29,12,0
2024-03-29,13,0
2024-03-29,14,0
2024-03-29,15,0
2024-03-29,16,0
2024-03-29,17,0
2024-03-29,18,0
2024-03-29,19,0
2024-03-29,20,0
2024-03-29,21,0
2024-03-29,22,0
2024-03-29,23,0
2024-03-30,0,0
2024-03-30,1,0
2024-03-30,2,0
2024-03-30,3,0
2024-03-30,4,0
2024-03-30,5,0
2024-03-30,6,0
2024-03-30,7,0
2024-03-30,8,0
2024-03-30,9,0
2024-03-30,10,0
2024-03-30,11,0
2024-03-30,12,0
2024-03-30,13,0
2024-03-30,14,0
2024-03-30,15,0
2024-03-30,16,0
2024-03-30,17,0
2024-03-30,18,0
2024-03-30,19,0
2024-03-30,20,0
2024-03-30,21,0
2024-03-30,22,0
2024-03-30,23,0
2024-03-31,0,0
2024-03-31,1,0
2024-03-31,2,0
2024-03-31,3,0
2024-03-31,4,0
2024-03-31,5,0
2024-03-31,6,0
2024-03-31,7,0
2024-03-31,8,0
2024-03-31,9,0
2024-03-31,10,0
2024-03-31,11,0
2024-03-31,12,0
2024-03-31,13,0
2024-03-31,14,0
2024-03-31,15,0
2024-03-31,16,0
2024-03-31,17,0
2024-03-31,18,0
2024-03-31,19,0
2024-03-31,20,0
2024-03-31,21,0
2024-03-31,22,0
2024-03-31,23,0
2024-04-01,0,0
2024-04-01,1,0
2024-04-01,2,0
2024-04-01,3,0
2024-04-01,4,0
2024-04-01,5,0
2024-04-01,6,0
2024-04-01,7,0
2024-04-01,8,0
2024-04-01,9,0
2024-04-01,10,0
2024-04-01,11,0
2024-04-01,12,0
2024-04-01,13,0
2024-04-01,14,0
2024-04-01,15,0
2024-04-01,16,0
2024-04-01,17,0
2024-04-01,18,0
2024-04-01,19,0
2024-04-01,20,0
2024-04-01,21,0
2024-04-01,22,0
2024-04-01,23,0
2024-04-02,0,0
2024-04-02,1,0
2024-04-02,2,0
2024-04-02,3,0
2024-04-02,4,0
2024-04-02,5,0
2024-04-02,6,0
2024-04-02,7,0
2024-04-02,8,0
2024-04-02,9,0
2024-04-02,10,0
2024-04-02,11,0
2024-04-02,12,0
2024-04-02,13,0
2024-04-02,14,0
2024-04-02,15,0
2024-04-02,16,0
2024-04-02,17,0
2024-04-02,18,0
2024-04-02,19,0
2024-04-02,20,0
2024-04-02,21,0
2024-04-02,22,0
2024-04-02,23,0
2024-04-03,0,0
2024-04-03,1,0
2024-04-03,2,0
2024-04-03,3,0
2024-04-03,4,0
2024-04-03,5,0
2024-04-03,6,0
2024-04-03,7,0
2024-04-03,8,0
2024-04-03,9,0
2024-04-03,10,0
2024-04-03,11,0
2024-04-03,12,0
2024-04-03,13,0
2024-04-03,14,0
2024-04-03,15,0
2024-04-03,16,0
2024-04-03,17,0
2024-04-03,18,0
2024-04-03,19,0
2024-04-03,20,0
2024-04-03,21,0
2024-04-03,22,0
2024-04-03,23,0
2024-04-04,0,0
2024-04-04,1,0
2024-04-04,2,0
2024-04-04,3,0
2024-04-04,4,0
2024-04-04,5,0
2024-04-04,6,0
2024-04-04,7,0
2024-04-04,8,0
2024-04-04,9,0
2024-04-04,10,0
2024-04-04,11,0
2024-04-04,12,0
2024-04-04,13,0
2024-04-04,14,0
2024-04-04,15,0
2024-04-04,16,0
2024-04-04,17,0
2024-04-04,18,0
2024-04-04,19,0
2024-04-04,20,0
2024-04-04,21,0
2024-04-04,22,0
2024-04-04,23,0
2024-04-05,0,0
2024-04-05,1,0
2024-04-05,2,0
2024-04-05,3,0
2024-04-05,4,0
2024-04-05,5,0
2024-04-05,6,0
2024-04-05,7,0
2024-04-05,8,0
2024-04-05,9,0
2024-04-05,10,0
2024-04-05,11,0
2024-04-05,12,0
2024-04-05,13,0
2024-04-05,14,0
2024-04-05,15,0
2024-04-05,16,0
2024-04-05,17,0
2024-04-05,18,0
2024-04-05,19,0
2024-04-05,20,0
2024-04-05,21,0
2024-04-05,22,0
2024-04-05,23,0
2024-04-06,0,0
2024-04-06,1,0
2024-04-06,2,0
2024-04-06,3,0
2024-04-06,4,0
2024-04-06,5,0
2024-04-06,6,0
2024-04-06,7,0
2024-04-06,8,0
2024-04-06,9,0
2024-04-06,10,0
2024-04-06,11,0
2024-04-06,12,0
2024-04-06,13,0
2024-04-06,14,0
2024-04-06,15,0
2024-04-06,16,0
2024-04-06,17,0
2024-04-06,18,0
2024-04-06,19,0
2024-04-06,20,0
2024-04-06,21,0
2024-04-06,22,0
2024-04-06,23,0
2024-04-07,0,0
2024-04-07,1,0
2024-04-07,2,0
2024-04-07,3,0
2024-04-07,4,0
2024-04-07,5,0
2024-04-07,6,0
2024-04-07,7,0
2024-04-07,8,0
2024-04-07,9,0
2024-04-07,10,0
2024-04-07,11,0
2024-04-07,12,0
2024-04-07,13,0
2024-04-07,14,0
2024-04-07,15,0
2024-04-07,16,0
2024-04-07,17,0
2024-04-07,18,0
2024-04-07,19,0
2024-04-07,20,0
2024-04-07,21,0
2024-04-07,22,0
2024-04-07,23,0
2024-04-08,0,0
2024-04-08,1,0
2024-04-08,2,0
2024-04-08,3,0
2024-04-08,4,0
2024-04-08,5,0
2024-04-08,6,0
2024-04-08,7,0
2024-04-08,8,0
2024-04-08,9,0
2024-04-08,10,0
2024-04-08,11,0
2024-04-08,12,0
2024-04-08,13,0
2024-04-08,14,0
2024-04-08,15,0
2024-04-08,16,0
2024-04-08,17,0
2024-04-08,18,0
2024-04-08,19,0
2024-04-08,20,0
2024-04-08,21,0
2024-04-08,22,0
2024-04-08,23,0
2024-04-09,0,0
2024-04-09,1,0
2024-04-09,2,0
2024-04-09,3,0
2024-04-09,4,0
2024-04-09,5,0
2024-04-09,6,0
2024-04-09,7,0
2024-04-09,8,0
2024-04-09,9,0
2024-04-09,10,0
2024-04-09,11,0
2024-04-09,12,0
2024-04-09,13,0
2024-04-09,14,0
2024-04-09,15,0
2024-04-09,16,0
2024-04-09,17,0
2024-04-09,18,0
2024-04-09,19,0
2024-04-09,20,0
2024-04-09,21,0
2024-04-09,22,0
2024-04-09,23,0
2024-04-10,0,0
2024-04-10,1,0
2024-04-10,2,0
2024-04-10,3,0
2024-04-10,4,0
2024-04-10,5,0
2024-04-10,6,0
2024-04-10,7,0
2024-04-10,8,0
2024-04-10,9,0
2024-04-10,10,0
2024-04-10,11,-0.12800000607967377
2024-04-10,12,0
2024-04-10,13,0
2024-04-10,14,0
2024-04-10,15,0
2024-04-10,16,0
2024-04-10,17,0
2024-04-10,18,0
2024-04-10,19,0
2024-04-10,20,0
2024-04-10,21,0
2024-04-10,22,0
2024-04-10,23,0
2024-04-11,0,0
2024-04-11,1,0
2024-04-11,2,0
2024-04-11,3,0
2024-04-11,4,0
2024-04-11,5,0
2024-04-11,6,0
2024-04-11,7,0
2024-04-11,8,0
2024-04-11,9,0
2024-04-11,10,0
2024-04-11,11,0
2024-04-11,12,0
2024-04-11,13,0
2024-04-11,14,0
2024-04-11,15,0
2024-04-11,16,0
2024-04-11,17,0
2024-04-11,18,0
2024-04-11,19,0
2024-04-11,20,0
2024-04-11,21,0
2024-04-11,22,0
2024-04-11,23,0
2024-04-12,0,0
2024-04-12,1,0
2024-04-12,2,0
2024-04-12,3,0
2024-04-12,4,0
2024-04-12,5,0
2024-04-12,6,0
2024-04-12,7,0
2024-04-12,8,0
2024-04-12,9,0
2024-04-12,10,0
2024-04-12,11,0
2024-04-12,12,0
2024-04-12,13,0
2024-04-12,14,0
2024-04-12,15,0
2024-04-12,16,0
2024-04-12,17,0
2024-04-12,18,0
2024-04-12,19,0
2024-04-12,20,0
2024-04-12,21,0
2024-04-12,22,0
2024-04-12,23,0
2024-04-13,0,0
2024-04-13,1,0
2024-04-13,2,0
2024-04-13,3,0
2024-04-13,4,0
2024-04-13,5,0
2024-04-13,6,0
2024-04-13,7,0
2024-04-13,8,0
2024-04-13,9,0
2024-04-13,10,0
2024-04-13,11,0
2024-04-13,12,0
2024-04-13,13,0
2024-04-13,14,0
2024-04-13,15,0
2024-04-13,16,0
2024-04-13,17,0
2024-04-13,18,0
2024-04-13,19,0
2024-04-13,20,0
2024-04-13,21,0
2024-04-13,22,0
2024-04-13,23,0
2024-04-14,0,0
2024-04-14,1,0
2024-04-14,2,0
2024-04-14,3,0
2024-04-14,4,0
2024-04-14,5,0
2024-04-14,6,0
2024-04-14,7,0
2024-04-14,8,0
2024-04-14,9,0
2024-04-14,10,0
2024-04-14,11,0
2024-04-14,12,0
2024-04-14,13,0
2024-04-14,14,0
2024-04-14,15,0
2024-04-14,16,0
2024-04-14,17,0
2024-04-14,18,0
2024-04-14,19,0
2024-04-14,20,0
2024-04-14,21,0
2024-04-14,22,0
2024-04-14,23,0
2024-04-15,0,0
2024-04-15,1,0
2024-04-15,2,0
2024-04-15,3,0
2024-04-15,4,0
2024-04-15,5,0
2024-04-15,6,0
2024-04-15,7,0
2024-04-15,8,0
2024-04-15,9,0
2024-04-15,10,0
2024-04-15,11,0
2024-04-15,12,-0.12800000607967377
2024-04-15,13,0
2024-04-15,14,0
2024-04-15,15,0
2024-04-15,16,0
2024-04-15,17,0
2024-04-15,18,0
2024-04-15,19,0
2024-04-15,20,0
2024-04-15,21,0
2024-04-15,22,0
2024-04-15,23,0
2024-04-16,0,0
2024-04-16,1,0
2024-04-16,2,0
2024-04-16,3,0
2024-04-16,4,0
2024-04-16,5,0
2024-04-16,6,0
2024-04-16,7,0
2024-04-16,8,0
2024-04-16,9,0
2024-04-16,10,0